상세 보기
Phase 3 randomized study of teclistamab plus daratumumab versus investigator's choice of daratumumab and dexamethasone with either pomalidomide or Bortezomib (DPd/DVd) in patients (Pts) with relapsed refractory multiple myeloma (RRMM): Results of majestec-3
- Mateos, Maria-Victoria;
- Bahlis, Nizar;
- Perrot, Aurore;
- Nooka, Ajay;
- Lu, Jin;
- ... Kim, Kihyun;
- 외 38명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0- 제목
- Phase 3 randomized study of teclistamab plus daratumumab versus investigator's choice of daratumumab and dexamethasone with either pomalidomide or Bortezomib (DPd/DVd) in patients (Pts) with relapsed refractory multiple myeloma (RRMM): Results of majestec-3
- 저자
- Mateos, Maria-Victoria; Bahlis, Nizar; Perrot, Aurore; Nooka, Ajay; Lu, Jin; Pawlyn, Charlotte; Mina, Roberto; Caeiro, Gaston; Kentos, Alain; Hungria, Vania; Reece, Donna; Niu, Ting; Mylin, Anne; Hansen, Charlotte; Teipel, Raphael; Besemer, Britta; Dimopoulos, Meletios; Zamagni, Elena; Yoshihara, Satoshi; Kim, Kihyun; Min, Chang-Ki; Geerts, Paulus; Van Leeuwen-Segarceanu, Elena; Tyczynska, Agata; Reguera, Juan Luis; Johansson, Magnus; Hansson, Markus; Turgut, Mehmet; Grey, Mark; Sidana, Surbhi; Rodriguez-Otero, Paula; Martinez-Lopez, Joaquin; Hashmi, Hamza; Carson, Robin; Kobos, Rachel; Sun, Weili; Lantz, Kristen; Seifert, Anne; Briseno-Toomey, Debbie; O'Rourke, Lisa; Rubin, Maria; Vieyra, Diego; Kang, Lijuan; Costa, Luciano
- 발행일
- 2025-11-24
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 146
- 페이지
- LBA6 ~ LBA8